Tumor Marker
The Potential Role of Angiopoietin-2 as a Diagnostic Tumor Marker for Hepatocellular Carcinoma
... vascularized tumor, and associated with portal infiltration, micro-vessel density, recurrence of HCC and decreased ...diagnostic tumor marker in HCC patients with liver ...potential tumor ...
8
Development of Electrochemical Aptamer Biosensor for Tumor Marker MUC1 Determination
... MUC1 tumor marker through the thiolated aptamers that went through immobilization onto the glassy carbon electrode (GCE) modified by Au nanoparticle (Au NP), we designed electrochemical aptasensors to ...
10
Tumor marker CA 15-3 in breast cancer patients
... The study included 100 patients with histo- logically verified breast cancer, with an av- erage age of 55.27±8.16 years. The average age of the patients in the study group was 54.74±8.41 years, while the control group ...
8
Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification
... between tumor marker CA125 and ovarian cancer stem cells, and obtained satisfactory results The second antibody labeled by monoclonal antibody of CA125 (OC125) and APC was used to isolate tumor cells ...
9
Design and Characterization of DNA Aptamer for Breast Tumor Marker by an Advantageous Method
... Our aim is to develop ssDNA aptamers, especially to design diagnostic assays and to develop biosensors for breast cancer through an easy to handle (enable work in an ordinary biomolecular laboratory), cost effective ...
7
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
... articles seem to concentrate more on randomized trials and epidemiological studies, but the methods and pro- blems of multivariable models in the latter are similar to prognostic studies. Concato et al . identified 44 ...
39
Assessment of EGFR /HER1 tumor marker in colorectal cancer among Sudanese patients
... In the developed & developing countries all over the world Colorectal cancer is the third most commonly diagnosed cancer in men and women in the world, and the third leading of cancer related death (Ng K, et al. ...
7
Prospective Clinical Application of Thioredoxin Reductase as a Novel Diagnostic Tumor Marker
... plasma tumor marker, thioredoxin reductase (TR), which is expressed in many types of malignant tumor, for the non-invasive detection of ...potential marker of malignant tumors with ...
10
Role of serum CA 19-9 as a tumor marker in TCC bladder
... An ideal tumour marker that can be used for TCC of bladder should be sensitive, specific, non-invasive, cost effective and easily available. Recently several biomarkers from peripheral blood or urine, have been ...
8
Expression of P16 Tumor Marker in Cervical Cancer among Sudanese Women
... multiple tumor suppressor 1 and as several other synonyms), is a tumor suppressor protein, that in humans is encoded by the CDKN2A ...a tumor suppressor that is implicated in the prevention of ...
6
Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
... a tumor- associated glycoprotein, are elevated in approximately 85% of patients with PDAC [25], and serum CA19-9 measurements can be used for diagnostic purposes ...a marker of recurrent disease after ...
8
Renal epithelioid angiomyolipoma with a negative premelanosome marker immunoprofile: a case report and review of the literature
... a tumor marker profile negative for several premelanosome ...The tumor was composed of sheets of pleomorphic, round to polygonal epithelioid cells with prominent eosinophilic cytoplasm, large nuclei, ...
6
ANTI NEOPLASTIC AND ANTI PEROXIDATIVE PROPERTIES OF NOBILETIN STUDIED IN BENZO(A) PYRENE INDUCED EXPERIMENTAL LUNG CANCER IN SWISS ALBINO MICE
... Adenosine deaminase (ADA) is an important enzyme in purine metabolism and has been documented as a tumor marker and increased activities are found in rapidly growing malignancies. [17] Increased ADA ...
12
Study Regarding Properties of Solid Tumors in Mammals
... spherical tumor and the “relative radius of the central zone to the total radius” ...steady-state tumor size, Greenspan [12] extended these models by considering that “a surface tension among the living ...
158
Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker
... correlate the biomolecular characteristics of CTCs with patient outcome, and to utilize this information for designing therapeutic trials. A recently initiated clinical trial (DETECT III) plans to use CTC HER2 status in ...
9
Use of Preoperative Ependymal Enhancement on Magnetic Resonance Imaging Brain as a Marker of Grade of Glioma.
... of tumor to ependyma, and the association to grade was ...the tumor grade preoperatively and by including LGGs, the role of SVZ in the heterogeneous disease process of glioma can be studied as a whole, not ...
6
Myosin 1e promotes breast cancer malignancy by enhancing tumor cell proliferation and stimulating tumor cell de-differentiation
... KO tumor cells may retain stable cell- cell junctions that maintain epithelial organization and allow fluid transport and accumulation in the lumens of mammary ...junction marker ZO-1 and the adherens ...
14
Genomics and epidemiology for gastric adenocarcinomas
... of tumor heterogeneity, where the amplification of HER2 is far from being homogeneous [82, 103], and can possibly impact the efficacy of Traztuzumab-treatment, as EVs may act as sponges sequestering the drug and ...
9
Original Article Musashi1 promotes tumor metastasis and is a prognostic marker for renal carcinoma
... We next analyzed the correlation between the expression of MSI1 and clinicopathological ch- aracteristics of RCC patients. As summarized in Table 1, high expression of MSI1 was signifi- cantly associated with ...
7
Functional Activity of Circulating Phagocytes as Potential Pretreatment Marker of Tumor Drug Resistance
... the tumor during its growth affects normal organs, tissues and regulatory systems of the body, imposing the peculiarities of its ...many tumor-related ...
15